CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues
Total revenues	$ 8,220,639	$ 6,279,428
Cost of revenues	3,222,390	3,447,622
Gross profit	4,998,249	2,831,806
Operating expenses
Selling, general and administrative	4,640,912	3,864,986
Depreciation and amortization	679,171	595,848
Total operating expenses	5,320,083	4,460,834
Loss from operations	(321,834)	(1,629,028)
Other income
Interest income, net	14,336	7,101
Loss before income tax provision	(307,498)	(1,621,927)
Income tax provision	1,897	1,600
Net loss	$ (309,395)	$ (1,623,527)
Net loss per share
Basic	$ (0.01)	$ (0.03)
Diluted	$ (0.01)	$ (0.03)
Weighted average common shares
Basic	51,818,676	50,351,971
Diluted	51,818,676	50,351,971
Plasma Industry [Member]
Revenues
Total revenues	$ 7,394,364	$ 5,383,151
Pharmaceutical industry [Member]
Revenues
Total revenues	806,568	882,830
Other Revenue [Member]
Revenues
Total revenues	$ 19,707	$ 13,447